Liang; Sidney X.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liang; Sidney X..The latest application filed is for "pyridinoylpiperidines as 5-ht1f agonists".

Company Profile

1.5.7

Liang; Sidney X. - Bethany CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyridinoylpiperidines As 5-HT1F Agonists App 20120329820 - Cohen; Michael P. ; et al.	2012-12-27
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation Grant 7,906,653 - Cantin , et al. March 15, 2	2011-03-15
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation App 20100204472 - Cantin; Louis-David ; et al.	2010-08-12
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation Grant 7,714,004 - Cantin , et al. May 11, 2	2010-05-11
Pyridonecarboxamide Derivatives Useful In Treating Hyper-proliferative And Angiogenesis Disorders App 20090306103 - Boyer; Stephen ; et al.	2009-12-10
Indane acetic acid derivatives and their use as pharmaceutical agents Grant 7,476,742 - Wickens , et al. January 13, 2	2009-01-13
5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes App 20080009531 - Cantin; Louis David ; et al.	2008-01-10
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders Grant 7,109,196 - Wang , et al. September 19, 2	2006-09-19
1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders App 20060189609 - Wang; Yamin ; et al.	2006-08-24
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders Grant 6,900,205 - Wang , et al. May 31, 2	2005-05-31
Indane acetic acid derivatives and their use as pharmaceutical agents App 20050107392 - Wickens, Philip ; et al.	2005-05-19
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders App 20040014751 - Wang, Yamin ; et al.	2004-01-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.